Have a personal or library account? Click to login
Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma Cover

Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma

Radiology and Oncology
Volume 59 (2025): Issue 2 (June 2025)
By: Katja Adamic,  Mateja Marc Malovrh,  Urska Bidovec Stojkovic and  Ales Rozman  
Open Access
|Jun 2025

Authors

Katja Adamic

katja.adamic@klinika-golnik.si

University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia

Mateja Marc Malovrh

University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Urska Bidovec Stojkovic

University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia

Ales Rozman

University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2025-0024 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 225 - 232
Submitted on: Dec 30, 2024
|
Accepted on: Jan 19, 2025
|
Published on: Jun 16, 2025
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
fibulin-3,
asbestos,
pleural effusion,
mesothelioma,
biomarker
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2025 Katja Adamic, Mateja Marc Malovrh, Urska Bidovec Stojkovic, Ales Rozman, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 59 (2025): Issue 2 (June 2025)Next article